Janney Montgomery Scott LLC Raises Stock Position in The Clorox Company (NYSE:CLX)

Janney Montgomery Scott LLC increased its position in The Clorox Company (NYSE:CLX - Free Report) by 5.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 115,552 shares of the company's stock after buying an additional 6,277 shares during the period. Janney Montgomery Scott LLC owned about 0.09% of Clorox worth $17,015,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Integral Investment Advisors Inc. boosted its holdings in Clorox by 4.1% in the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company's stock worth $279,000 after buying an additional 67 shares during the period. Sonora Investment Management Group LLC boosted its holdings in shares of Clorox by 2.5% during the 1st quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock valued at $433,000 after purchasing an additional 72 shares during the last quarter. Sound View Wealth Advisors Group LLC boosted its holdings in shares of Clorox by 6.1% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company's stock valued at $218,000 after purchasing an additional 77 shares during the last quarter. Wedbush Securities Inc. boosted its holdings in shares of Clorox by 1.2% during the 4th quarter. Wedbush Securities Inc. now owns 7,624 shares of the company's stock valued at $1,238,000 after purchasing an additional 94 shares during the last quarter. Finally, Aviance Capital Partners LLC boosted its holdings in shares of Clorox by 3.2% during the 4th quarter. Aviance Capital Partners LLC now owns 3,180 shares of the company's stock valued at $516,000 after purchasing an additional 100 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have commented on CLX. Evercore ISI set a $140.00 price objective on shares of Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. JPMorgan Chase & Co. dropped their price objective on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a report on Tuesday, May 6th. Morgan Stanley dropped their price objective on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. UBS Group dropped their price objective on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. Finally, Citigroup dropped their price objective on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a report on Monday, April 14th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $151.23.

Insiders Place Their Bets

In other news, Director Pierre R. Breber acquired 4,000 shares of the firm's stock in a transaction on Wednesday, May 7th. The stock was acquired at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director now directly owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.57% of the stock is owned by insiders.

Clorox Trading Down 0.1%

Shares of NYSE:CLX traded down $0.12 during trading on Friday, reaching $120.81. The company's stock had a trading volume of 4,705,254 shares, compared to its average volume of 1,362,826. The company has a current ratio of 0.74, a quick ratio of 0.44 and a debt-to-equity ratio of 13.07. The Clorox Company has a 12 month low of $120.33 and a 12 month high of $171.37. The firm's 50 day simple moving average is $133.11 and its two-hundred day simple moving average is $146.77. The stock has a market capitalization of $14.89 billion, a PE ratio of 21.69, a price-to-earnings-growth ratio of 2.73 and a beta of 0.54.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The firm's revenue for the quarter was down 8.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.71 EPS. On average, research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.